Variables | Surfactant group (n = 67) | Surfactant + budesonide group (n = 67) | |
---|---|---|---|
Gestational age (week) | Mean (SD) | 31 ± 2.96 | 31.66 ± 2.84 |
Birth weight (gr) | Mean (SD) | 1465.45 ± 520.88 | 1584.55 ± 505.02 |
Maternal age (year) | Mean (SD) | 29.97 ± 6.45 | 29.12 ± 4.86 |
Delivery mode | NVD (n %) | 19(28.4%) | 18(26.9%) |
CS (n %) | 48(71.6%) | 49(73.1%) | |
Sex | Male (n %) | 40(59.7%) | 29(43.3%) |
Female (n %) | 27(40.3%) | 38(56.7%) | |
Maternal medical problems | Yes | 22(32.8%) | 19(28.4%) |
No | 45(67.2%) | 48(71.6%) | |
Antenatal drug | No | 32(47.8%) | 33(49.3%) |
Betamethasone | 11(16.4%) | 17(25.4%) | |
Levothyroxine | 3(4.5%) | 5(7.5%) | |
Combination | 21(31.3%) | 12(17.9%) | |
Gestational age (week) | < 30 | 24(35.8%) | 16(23.9%) |
30–34 | 39(58.2%) | 32(47.8%) | |
> 34 | 12(17.9%) | 11(16.4%) | |
Birth weight (gr) | < 1500 | 30(44.8) | 40(59.7) |
1500–2000 | 22(32.8) | 13(19.4) | |
> 2000 | 15(22.4) | 14(20.9) |